Latest stories on NVS
Novartis: More Pain on the Way?
Barron's32 · bearishgeneral
Novartis heart drug pelacarsen fails Phase 3 clinical trial
Quartz28 · bearishproduct/pr
Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth Pipeline
Yahoo Top28 · bearishproduct/pr
Novartis investors turn spotlight on M&A after trial setbacks
Yahoo Top38 · neutralgeneral
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
Yahoo Top34 · bearishgeneral
Amgen Drops 10% on a Trial It Didn't Even Run
MarketBeat32 · bearishearnings
Novartis investors to increase scrutiny of company’s strategy, Reuters reports
The Fly46 · neutralgeneral
Novartis investors turn spotlight on M&A after trial setbacks
Investing.com Markets42 · neutralgeneral
BofA Sees Limited Damage from Novartis (NVS)’ Pelacarsen Miss While Citi Looks Towards Ionis (IONS)
Yahoo Finance42 · neutralproduct/pr
Novartis stock in hot water after another key failure
Yahoo Top28 · bearishproduct/pr
Novartis stock in hot water after another key failure
The Street28 · bearishproduct/pr
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure?
Yahoo Top34 · bearishproduct/pr
Novartis facing board change threat from shareholder following trial failures
Seeking Alpha34 · bearishgeneral
Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks
Yahoo Finance38 · neutralgeneral
Novartis shareholder calls for board changes, Reuters reports
The Fly48 · neutralgeneral
Health Care Roundup: Market Talk
WSJ Markets50 · neutralgeneral
Novartis Needs Board Shakeup and M&A Revamp, Investor Says
Bloomberg42 · neutralgeneral
Stocks making the biggest moves premarket: Macy's, Meta, Apple, Novartis and more
CNBC50 · neutralgeneral
Artisan Partners calls for Novartis board changes amid trial, acquisition failures
Investing.com Markets38 · neutralgeneral
Exclusive-Major Novartis shareholder calls for board shake-up after drug trial setbacks
Investing.com Markets38 · neutralgeneral
Why is Novartis stock recovering today?
Investing.com Markets55 · neutralgeneral
HSBC upgrades Novartis to Hold with negative catalysts played out
The Fly56 · neutralanalyst
HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
Investing.com Markets58 · neutralanalyst
HSBC upgrades Novartis stock rating to hold on pipeline clarity
Investing.com Analyst Ratings56 · neutralanalyst